Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
S. Yoo (Daegu, Republic of Korea). Association between polymorphisms in microRNA target sites using CLASH data and survival of early-stage non-small cell lung cancer. 3309

Member's Comments

No comment yet.

Related content which might interest you: Investigation of survivin gene polymorphism in non-small cell lung cancer patients (NSCLC) Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Association of KIR genes and their ligands with non-small cell lung cancer Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010 A polymorphism, which exists intronic lesion of SLC5A10, affects DRG2 expression and survival outcome of early-stage non-small cell lung cancer Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Polymorphisms in mitotic checkpoint-related genes can influence survival outcomes of early-stage non-small cell lung cancer Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017 The effects of polymorphisms identified in genome-wide association studies of never-smoking females on the prognosis of non-small cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Gene modules in non-small cell lung cancer Source: Annual Congress 2009 - Basic science and lung cancer Year: 2009 Evaluation of promoter hypermethylation in tissue and blood of non-small cell lung cancer patients and association with survival. Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018 Polymorphisms in the interleukin-10 gene promoter are associated with susceptibility to non-small cell lung cancer (NSCLC) Source: Eur Respir J 2005; 26: Suppl. 49, 458s Year: 2005 Different expression of miRNA in non-small cell lung cancer according to its clinical stage Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008 Association of Pre-miR-rs2910164 polymorphism with non-small cell lung cancer in an Iranian population Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018 Characterization of patients with non-small cell lung cancer (NSCLC) relative to its EGFR mutational status Source: Annual Congress 2011 - Epidemiology of lung cancer and screening Year: 2011 XAGE-1b and p53: Potential targets for immunotherapy of non-small cell lung cancer (NSCLC) Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012 24h-blood profile gene expression biomarkers of the response to bevacizumab-erlotinib (BE) in advanced non-squamous non-small cell lung cancer (NSCLC) Source: International Congress 2016 – Therapeutic trials in lung cancer Year: 2016 Gene expression profiles predict survival of patients with advanced non-small cell lung cancers Source: Annual Congress 2010 - New mechanisms and markers in human lung cancer Year: 2010 Gene expression profiling in non-small cell lung cancer (NSCLC) according to smoking status Source: Annual Congress 2008 - Discovery of novel targets in lung disease by means of functional genomics Year: 2008 A variant in LKB1 gene can predicts the clinical outcomes of chemotherapy in patients with non-small cell lung cancer Source: International Congress 2018 – Lung cancer: new aspects in diagnosis and management Year: 2018 Prognostic value of ERCC1 expression in advanced non-small cell lung cancer (NSCLC) Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Is MIF -173G/C polymorphism associated with in non-small cell lung cancer (NSCLC) susceptibility? Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Choice of endogenous control for gene expression in nonsmall cell lung cancer Source: Eur Respir J 2005; 26: 1002-1008 Year: 2005 Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival Source: Eur Respir J 2011; 37: 617-623 Year: 2011